149 related articles for article (PubMed ID: 37295160)
1. Multi-action platinum(IV) prodrugs conjugated with COX-inhibiting NSAIDs.
Liu X; Wenisch D; Dahlke P; Jordan PM; Jakupec MA; Kowol CR; Liebing P; Werz O; Keppler BK; Weigand W
Eur J Med Chem; 2023 Sep; 257():115515. PubMed ID: 37295160
[TBL] [Abstract][Full Text] [Related]
2. Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position.
Spector DV; Pavlov KG; Akasov RA; Vaneev AN; Erofeev AS; Gorelkin PV; Nikitina VN; Lopatukhina EV; Semkina AS; Vlasova KY; Skvortsov DA; Roznyatovsky VA; Ul'yanovskiy NV; Pikovskoi II; Sypalov SA; Garanina AS; Vodopyanov SS; Abakumov MA; Volodina YL; Markova AA; Petrova AS; Mazur DM; Sakharov DA; Zyk NV; Beloglazkina EK; Majouga AG; Krasnovskaya OO
J Med Chem; 2022 Jun; 65(12):8227-8244. PubMed ID: 35675651
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug-Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines.
Barth MC; Häfner N; Runnebaum IB; Weigand W
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982792
[TBL] [Abstract][Full Text] [Related]
4. Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity.
Aher S; Zhu J; Bhagat P; Borse L; Liu X
Top Curr Chem (Cham); 2024 Feb; 382(1):6. PubMed ID: 38400859
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of antitumor platinum(II) agents conjugated with non-steroidal anti-inflammatory drug species.
Zang J; Zhang B; Wang Y; Wang X; Gou S
Bioorg Chem; 2022 Mar; 120():105633. PubMed ID: 35091288
[TBL] [Abstract][Full Text] [Related]
6. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen
Ravera M; Zanellato I; Gabano E; Perin E; Rangone B; Coppola M; Osella D
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238499
[TBL] [Abstract][Full Text] [Related]
8. New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo.
Song XQ; Ma ZY; Wu YG; Dai ML; Wang DB; Xu JY; Liu Y
Eur J Med Chem; 2019 Apr; 167():377-387. PubMed ID: 30784875
[TBL] [Abstract][Full Text] [Related]
9. Novel 4-Amino-Quinazoline moieties ligated Platinum(IV) prodrugs overcome cisplatin resistance in EGFR
Li R; Zhao W; Jin C; Xiong H
Bioorg Chem; 2023 Jun; 135():106499. PubMed ID: 37058978
[TBL] [Abstract][Full Text] [Related]
10. Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria.
Chen H; Chen F; Hu W; Gou S
J Inorg Biochem; 2018 Mar; 180():119-128. PubMed ID: 29253663
[TBL] [Abstract][Full Text] [Related]
11. Platinum (IV) drugs with cannabidiol inducing mitochondrial dysfunction and synergistically enhancing anti-tumor effects.
Wei T; Chen L; Shi P; Wang C; Peng Y; Yang J; Liao X; Yang B; Gao C
J Inorg Biochem; 2024 May; 254():112515. PubMed ID: 38490045
[TBL] [Abstract][Full Text] [Related]
12. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
Chen F; Qin X; Xu G; Gou S; Jin X
Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
[TBL] [Abstract][Full Text] [Related]
13. Platinum(IV) Derivatives of [Pt(1
Kostrhunova H; McGhie BS; Markova L; Novakova O; Kasparkova J; Aldrich-Wright JR; Brabec V
J Med Chem; 2023 Jun; 66(12):7894-7908. PubMed ID: 37285472
[TBL] [Abstract][Full Text] [Related]
14. Multi-action Pt(IV) anticancer agents; do we understand how they work?
Gibson D
J Inorg Biochem; 2019 Feb; 191():77-84. PubMed ID: 30471522
[TBL] [Abstract][Full Text] [Related]
15. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
Qiao X; Gao YY; Zheng LX; Ding XJ; Xu LW; Hu JJ; Gao WZ; Xu JY
Eur J Med Chem; 2021 Nov; 223():113730. PubMed ID: 34388483
[TBL] [Abstract][Full Text] [Related]
16. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
[TBL] [Abstract][Full Text] [Related]
17. An Anticancer Pt
Kostrhunova H; Petruzzella E; Gibson D; Kasparkova J; Brabec V
Chemistry; 2019 Apr; 25(20):5235-5245. PubMed ID: 30740808
[TBL] [Abstract][Full Text] [Related]
18. Pt(IV) Prodrugs with NSAIDs as Axial Ligands.
Spector D; Krasnovskaya O; Pavlov K; Erofeev A; Gorelkin P; Beloglazkina E; Majouga A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917027
[TBL] [Abstract][Full Text] [Related]
19. Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study.
Ratzon E; Najajreh Y; Salem R; Khamaisie H; Ruthardt M; Mahajna J
BMC Cancer; 2016 Feb; 16():140. PubMed ID: 26906901
[TBL] [Abstract][Full Text] [Related]
20. Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents.
Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]